XML 21 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating Activities    
Net loss $ (7,112) $ (9,786)
Adjustments to reconcile net loss to net cash used for operating activities:    
Depreciation 1,520 2,709
Net periodic costs and contributions related to employee benefit plans (899) (4,090)
Bad debt expense (benefit) (65) 307
Deferred income taxes 11 (25)
Gain on short-term investments (401)  
Provision, interest and penalties for uncertain tax positions (102) 9
Loss on sale/disposal of assets, net   58
Asset impairments   102
Changes in working capital and other operating assets and liabilities:    
Accounts receivable 4,165 1,682
Inventories, prepaids and other current assets 1,545 (400)
Other assets 19 388
Accounts payable (1,078) (2,780)
Compensation and benefit obligations (253) (778)
Other accrued expenses 1,525 (170)
Contract liabilities 7 (1,088)
Other post-employment benefits (56) (71)
Net cash used for operating activities (1,174) (13,933)
Investing Activities    
Purchases of assets (1,148) (1,627)
Purchases of short-term investments (10,500)  
Return on short-term investments 120  
Note payment received for asset sales   22,400
Net cash provided by (used for) investing activities (11,528) 20,773
Financing Activities    
Dividends paid (3,426) (11,454)
Net cash used for financing activities (3,426) (11,454)
Net decrease in cash and cash equivalents (16,128) (4,614)
Cash and cash equivalents, beginning of period 27,825 32,439
Cash and cash equivalents, end of period 11,697 27,825
Supplemental Disclosures    
Income tax paid, net 594 619
Noncash investing and financing activities:    
Investments in property, plant and equipment payable 33  
Dividends payable $ 856 $ 856